We are live on
!
Find out more
Lilly Endowment Portfolio holdings
AUM
$108B
1-Year Est. Return
53.87%
This Fund
S&P 500
This Quarter
Est. Return
-13.51%
1 Year Est. Return
+53.87%
3 Year Est. Return
+155.75%
5 Year Est. Return
+422.58%
10 Year Est. Return
+1,423.09%
AUM
$6.66B
AUM Growth
–
Cap. Flow
+$7.38B
Cap. Flow
% of AUM
110.77%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$7.38B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.08T
| $6.66B | 100% |
+135,670,804
| New | +$7.38B |
|
Similar funds
Lilly Endowment's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Lilly Endowment, which disclosed 1 position worth $6.66B. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Eli Lilly: 135,670,804 shares worth $6.66B.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Lilly Endowment's largest Q2 2013 buy was Eli Lilly: 135,670,804 shares worth $6.66B.
- Lilly Endowment's ten largest holdings make up 100% of its $6.66B portfolio in Q2 2013.
- Lilly Endowment disclosed 1 position in Q2 2013, its first 13F filing on record.
Based on Lilly Endowment's 13F filing for Q2 2013, filed 16 Jul 2013.